# Comparison of Age-related Macular Degeneration Treatments Trials: Lucentis-Avastin Trial

> **NCT00593450** · PHASE3 · COMPLETED · sponsor: **University of Pennsylvania** · enrollment: 1208 (actual)

## Conditions studied

- Age Related Macular Degeneration

## Interventions

- **DRUG:** ranibizumab
- **DRUG:** bevacizumab

## Key facts

- **NCT ID:** NCT00593450
- **Lead sponsor:** University of Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-02
- **Primary completion:** 2010-12
- **Final completion:** 2015-04
- **Target enrollment:** 1208 (ACTUAL)
- **Last updated:** 2017-08-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00593450

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00593450, "Comparison of Age-related Macular Degeneration Treatments Trials: Lucentis-Avastin Trial". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00593450. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*